XOMAPXOMA Corporation

$309M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$896,000-97.5% YoY

Gross Profit

$259,00028.9% margin

Operating Income

-$5M-592.3% margin

Net Income

-$5M-510.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-60.3%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$847,000

Balance Sheet

Total Assets

$46M

Total Liabilities

$45M

Stockholders' Equity

$1M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$896,000	$36M	-97.5%
Gross Profit	$259,000	$35M	-99.3%
Operating Income	-$5M	$29M	-118.5%
Net Income	-$5M	$26M	-117.4%

XOMAP Q3 2018 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena